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Summary 
The Bloom’s syndrome (BS) gene, BLM, plays an im- 
portant role in the maintenance of genolmic stability 
in somatic cells. A candidate for BLM was identified 
by direct selection of a cDNA derived from a 250 kb 
segment of the genome to which BLM had been as- 
signed by somatic crossover point mapping. In this 
novel mapping method, cells were used from persons 
with BS that had undergone intragenic recombination 
within ELM. cDNA analysis of the candidatle gene iden- 
tified a 4437 bp cDNA that encodes a 1417 amino acid 
peptide with homology to the RecQ helicases, a sub- 
family of DExH box-containing DNA and RNA heli- 
cases. The presence of chain-terminating mutations 
in the candidate gene in persons with BS proved that 
it was BLM. 
Introduction 
Bloom’s syndrome (BS) (reviewed by German, 1993) is a 
rare genetic disorder, the major clinical manifestations of 
which are small size, sun-sensitive facial erythema, and 
immunodeficiency. Homozygosity for mutation at BLM, 
the f3S locus, constitutes a mutator genotype: somatic 
cells from persons with BS accumulate excessive num- 
bers of mutations at all loci examined, including both cod- 
ing sequences and noncoding repetitive DNA. Excessive 
numbers of chromatid gaps and breaks are visible in cul- 
tured but otherwise untreated cells, and exchanges be- 
tween chromatids are increased in number. Interchanges 
between homologous chromosomes are increased, signi- 
fying increased somatic crossing over, and an abnormally 
great number of sister chromatid exchanges (SCEs) are 
present in bromodeoxyuridine (BrdU)-treated cells. Molec- 
ular studies have confirmed the increased rate of somatic 
recombination in BS cells. An important clinical conse- 
quence of the excessive genomic instability of BS is an 
enormous predisposition to the generality of human cancers. 
tThe first two authors contributed equally to this work. 
Cytogenetic and biochemical evidences have shown 
that various aspects of DNA replication are disturbed in 
BS cells. However, the biochemical candidate gene ap- 
proach to the identification of the primary enzymatic defect 
had been unsuccessful, in part owing to the numerous 
cellular effects of the BS phenotype; therefore, positional 
cloning was initiated. BLM, already assigned to human 
chromosome 15 (McDaniel and Schultz, 1992), was re- 
gionally mapped by the analysis of affected persons whose 
Parents are cousins (German et al., 1994). Tight linkage 
was demonstrated between BLM and FES, a gene local- 
ized to band 15q26.1 by fluorescence in situ hybridization 
(Mathew et al., 1993). Because the data from the homozy- 
gosity mapping indicated that BLM was situated within 1 
CM of FES, a yeast artifical chromosome (YAC) {and Pl 
contig of the region flanking FES was constructed, and 
polymorphic markers in that region were identified 
(Straughen et al., submitted). Recently, a discovery was 
made that led to a powerful approach to localize BLM ex- 
actly. 
The hypermutability of BS cells includes hyperirecom- 
binability. Although cells from all persons with BS exhibit 
the diagnostic high SCE rate, in some persons a minor 
population of low SCE lymphocytes exists in the blood. 
Lymphoblastoid cell lines (LCLs) with low SCE ratles can 
be developed from these low SCE lymphocytes. In multiple 
low SCE LCLs examined from 11 persons with BS, poly- 
morphic loci distal to BLM on 15q had become homozy- 
gous in LCLs from five persons, whereas polymorphic loci 
proximal to BLM remained heterozygous in all low SCE 
LCLs. These observations supported the hypothesis that 
low SCE lymphocytes arose through recombination within 
BLM in persons with BS who had inherited paternally and 
maternally derived BLM alleles mutated at different sites. 
Such a recombinational event in a precursor stem cell in 
these compound heterozygotes gave rise to a cell whose 
progeny had a functionally wild-type gene and phenotypi- 
tally a low SCE rate (Ellis et al., 1995). 
The low SCE LCLs in which reduction to homozygosity 
had occurred were used for localizing BLM by an approach 
we refer to as somatic crossover point (SCP) mapping. 
The precise map position of BLM was determined by com- 
paring the genotypes of the recombinant low SCE LCLS 
from the five persons mentioned above with their constitu- 
tional genotypes at loci in the region around BLM. The 
strategy was to identify the most proximal polymorphic 
locus possible that was constitutionally heterozygous and 
that had been reduced to homozygosity in the low SCE 
LCLs, and to identify the most distal polymorphic locus 
possible that had remained constitutionally heterozygous 
in them. BLM would have to be in the short interval defined 
by the reduced (distal) and the unreduced (proximal) het- 
erozygous markers. The power of this approach was lim- 
ited only by the density of polymorphic loci available in 
the immediate vicinity of BLM. In this report, we describe 
the SCP mapping, isolation, and identification of BLM. 
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Results 
Localization of ELM to a 250 kb Interval 
BLM previously was localized by SCP mapping to a 1.3 
CM interval bounded proximally by D75S776 and distally 
by four tightly linked loci D75S727, FES, D75S758, and 
IP75M9 (Ellis et al., 1995). The four loci are present in a 
l-2 CM interval on chromosome 15 (Beckmann et al., 
1993; Gyapay et al., 1994). The order of these four loci 
was determined by polymerase chain reaction (PCR) anal- 
ysis of clones in a 2 Mb YAC and Pl contig that encom- 
passes BLM (Straughen et al., submitted). The four loci 
were oriented with respect to the telomere by finding a 
recombinant chromosome in a BS family in which crossing 
over had occurred between BLM and IP75M9, placing 
IP75M9 on the distal end of the contig (Figure 1A). Be- 
cause 0758727 was the most proximal locus that was 
reduced to homozygosity in low SCE LCLs, polymorphic 
loci in the region proximal to it were sought. There, a poly- 
morphic locus, D75S7708, was identified that remained 
constitutionally heterozygous in the recombinant low SCE 
LCLs, in contrast with locus D75S727, which had become 
homozygous in them (Figure 1 B). This shift from heterozy- 
gosity to homozygosity of markers indicated that BLM is 
situated in the 250 kb region between D75S7708 and 
0758727. 
Two genes, FES and FUR, map distal to D75S727 in 
this region of chromosome 15. SCP mapping thereby elim- 
A 
B 
Il(laTh) 59(FrFit) 87(AIFra) 
D15SllO8 PF Ph p’ p’ FR4 PF Ph p’ FM PF Ph p’ FM 
D15S127 PF Ph p’ P’ FM PF Ph p’ FM PF Ph Pl FM 
NR8(KeSol) 
PF Ph d FTvf 
Figure 1. SCP Mapping of ELM 
(A) Genetic map of the BLM region of 15q. On 
the upper horizontal line, the order and dis- 
tances (shown in kilobases) between the poly 
morphic microsatellite loci were estimated by 
long-range restriction mapping (Straughen et 
al., submitted). The distance between 0159127 
and FES (not indicated) was determined to be 
30 kb by restriction enzyme mapping of a cos- 
mid contig (see below). Vertical lines indicate 
the position of the marker loci, and the circle 
represents the centromere. The interval be- 
tween loci D75S7708 and 0753727 is ex- 
panded below the map. Vertical lines inter- 
secting mark the unmethylated CpG-rich 
regions identified by long-range restriction 
mapping, and arrows indicate the direction of 
transcription of three genes in the region. Cer- 
tain YACs (Y), Pls (P), and cosmids (c) from 
the contig (Straughen et al., submitted) are de- 
picted by horizontal lines underneath the map. 
Dashes on the YAC lines indicate internal dele- 
tions. At the top, the horizontal cross-hatched 
bars indicate regions proximal to BLM that re- 
mained heterozygous in the low SCE LCLs and 
regions distal to BLMthat had become homozy- 
gous. The minimal region to which BLM was 
thus assigned by SCP mapping is represented 
by a closed box. 
(B)Autoradiographicevidenceshowing hetero- 
zygosity proximal to BLM and reduction to ho- 
mozygosity distal to BLM. The four persons of 
five from whom low SCE LCLs had been estab- 
lished that were informative at DlBS7708 or 
0158727 are shown. To determine both the 
constitutional and the recombinant cell line ge- 
notypes, we carried out PCRs using DNA sam- 
ples prepared from high SCE cells (P”) and low 
SCE LCLs (PI) of persons with BS as well as 
samples from their fathers (PF) and their moth- 
ers (PM). These persons are identified by their 
Bloom’s Syndrome Registry designations (see 
German and Passarge, 1989). Arrows point to 
DNA fragments amplified from the heterozy- 
gous alleles of the constitutional genotypes, 
pat (for paternal) and mat (for maternal). Aster- 
isks mark alleles in the low SCE LCLs that are lost through somatic crossing over. Lines mark DNA fragments amplified from alleles of the parents 
but that were not transmitted to the offspring with BS. From one of the four persons with BS, 11 different clonal LCLs were examined; three of 
the 11 had undergone reduction to homozygosity at loci distal to BLM, as explained elsewhere (Ellis et al., 1995). Autoradiographic patterns are 
shown from two of the 1 I low SCE LCLs from 1 l(laTh), one representative of cell lines in which allele losses were detected (P’ sample on right) 
and another of cell lines in which they were not (P’ sample on left). 
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Figure 2. The 4437 bp Hi -5’Sequence, Which Represents the Merged 
Sequences of the Hl cDNA and the 5’ Clones, with Its Encoded 1417 
Residue Amino Acid Sequence in Single Letter Code 
Nucleotides in the open reading frame starting at the first in-frame 
ATG, 75 bp from the first nucleotide of the Hi-5’sequence, are capital- 
ized. The in-frame nonsense codon (TAA) marked by the period is 
followed by 66 nt of 3’ untranslated sequence. At the initiator methio- 
inated them as candidates for BLM. Consistent with this 
conclusion, an earlier mutation search in six BS LCLs had 
failed to uncover mutations in FUR (data not shown). 
Isolation of a Candidate for BLM 
cDNAs were isolated from the 250 kb region between 
D75S1108 and D15Sl27 by direct cDNA selection using 
cDNA libraries from cultured fibroblasts and the ‘T cell line 
Jurkat. Libraries from these cell lines were chosen be- 
cause fibroblasts and T lymphocytes from persons with 
BS exhibit the high SCE phenotype, indicating ithat BLM 
is expressed in these cell types. In direct selectio’n experi- 
ments using cosmid c905 (see Figure 1 A), an 847 bp cDNA 
designated 905-28 was isolated after two rounds of direct 
selection. It was found in fewer than 1 in 1 x 106 clones 
screened in the fibroblast library but was present in 6 of 
28 selected cDNA clones, a 250,000-fold enrichment. The 
six cDNAs represented by 905-28 were the only selected 
cDNAs that by Southern blot analysis mapped to the BLM 
region and that identified nonrepetitive sequences in the 
human genome (data not shown). The 905-28 cDNlA identi- 
fied single-copy sequences that are situated approxi- 
mately 5.5 kb proximal to FUR (Figure 1A). 
The 905-28 cDNA then was used to screen a HeLa 
cDNA library; 28 cDNAs were isolated, representing at 
least 15 distinct classes of overlapping clones. Each of 
these classes had the same sequence as the 905-28cDNA 
at the 3’ ends but a different length of 5’ sequence. In the 
longest cDNA isolated, clone Hl , a long reading frame was 
found that was open to the 5’ end. Additional sequences 
upstream of the start of the Hl cDNA were identified by 
a PCR cloning method (see Experimental Procedures). 
Clones extending 5’ of the Hl cDNA were isolated from 
the HeLa library, permitting the identification of 4437 bp 
of sequence, which we refer to as the Hl-5’ sequence 
(Figure 2). 
Starting at the first in-frame ATG 75 bp from its 5’ end, 
the Hl-5’ sequence encodes a 1417 amino acid peptide 
with a predicted molecular mass of 159 kDa. No irn-frame 
stop codons were present between this ATG and the 5’ 
end of the Hl-5’ sequences. An extensive cDNA analysis 
was carried out to map the 5’ end of the candidatle gene. 
We screened 8 x 1 O6 LCL cDNA clones by hybridization 
with a 5’ probe. We isolated 11 clones and seqluenced 
their 5’ ends (Figure 3). In addition, 12 fibroblast clones 
prepared by a 5’ rapid amplification of cDNA ends (RACE) 
technique were sequenced. Both analyses indicated that 
the Hl-5’ sequence is full length. 
The predicted peptide encoded in the Hl-5’ sequence 
was used to carry out a BLASTP search of amino acid 
nine, there is a Kozak consensus sequence (Kozak, 1969), and an 
acceptable polyadenylation sequence (underlined) is present 20 bp 
upstream of a 21 bp poly(A) tail. Sites at which substitution or deletion 
were detected in persons with BS (see Table 1) are boxed, and a site 
at which an insertion was identified is marked by a diamond. l-he Eagl 
and Smal sites used in the construction of a full-length cDNA referred 
to as 83 (see Experimental Procedures) are overlined. Asterisks mark 
amino acid identities to three motifs present in the RNA polymerase 
II largest subunit (see text). 
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5s 
in Figure 3. Nucleotide Sequence of the 5’ End 
7 “77 
i, lxaa 
P r 
of the Candidate Gene Determined by cDNA 
Analysis and 5’ RACE Experiments 
5'end GCTTCCGGCGGAAGTGAGCCAGGGC'ITGGCGCGGCGGCC The sequence of the longest cDNA isolated 
: 2 1 A 
(clone Rl) is shown. The sequences were ob- 
$1 =isz 
tained by analysis of 11 lymphoblastoid cDNAs 
(clone names prefixed by an R), identified by 
screening 6 x 10” clones with an Eagl-Smal DNA fragment from the 5’part of the Hl-5’sequence (Figure 2) and of 12 5’ RACE clones amplified 
from fibroblast cDNA with nested PCR primers (see Experimental Procedures). Vertical lines mark the nucleotides at which nine lymphoblastoid 
cDNA (clones named above the sequences) and six cloned 5’ RACE fragments (clones named below the sequences) initiated. Three cDNA and 
six 5’ RACE clones not shown contained sequences that initiated less than 36 bp upstream of the first in-frame ATG. The sequences at the 5 
end are GC rich (71%) perhaps explaining the absence of in-frame nonsense codons uostream of the first in-frame ATG. 
sequence databases. The searches identified significant 
homologies to the three known peptides in the RecQ sub- 
family of DExH box-containing helicases (Figure 4). The 
amino acid identities were concentrated in the region (resi- 
dues 649-1041) containing the seven conserved helicase 
domains of the human RECQL (44%), Saccharomyces 
cerevisiae SGS7 (43%) and Escherichia coli recQ (42%) 
genes. Thus, the product of the candidate gene contains 
motifs homologous to those found in DNA helicases, sug- 
gesting that the protein is an enzyme engaged in DNA 
manipulation. 
The seven helicase domains identified by their homol- 
ogy to RecQ constitute only the middle third of the pre- 
dicted peptide. Between residues 588 and 661, amino acid 
identities were discovered with three short motifs present 
in a broad phylogenetic spectrum of RNA polymerase II 
largest subunits (marked by asterisks in Figure 2). The 
function of these motifs is unknown. No other significant 
homologies were identified to amino acid sequences in 
databases. 
The amino acid composition of the nonhelicase regions 
of the predicted peptide is unusual. The amino-terminal 
648 residues of the peptide are rich in acidic (17%), basic 
(120/o), and polar (34%) amino acids; 13% of the residues 
are serines. Similarly, the carboxy-terminal 376 residues 
also are rich in acidic (1 lo/o), basic (16%) and polar (30%) 
amino acids; and, again, 14% of the residues are serines. 
The function of these highly charged regions is unknown. 
RNA Expression of the Candidate Gene 
in Cultured Cells 
Northern blot analysis was used to determine the size of 
the full-length transcript from the candidate gene. The Hl 
cDNA was hybridized to total RNAs prepared from HeLa 
cells, normal diploid cultured fibroblasts, and non-BS 
LCLs. Two RNA bands at approximately 4.5 kb were visu- 
alized on the autoradiogram (Figure 5A). This size is con- 
sistent with the length of the longest cDNAs sequenced 
(see Figures 2 and 3). 
In addition, Northern blot analysis was performed using 
total RNAs prepared from LCLs from seven unrelated per- 
sons with BS (Figure 56). In three BS LCLs, the quantity 
of RNAs identified by hybridization to the Hl cDNA was 
decreased in comparison to that of the control LCLs. In 
four BS LCLs, the pattern of the two RNA bands was abnor- 
mal compared to that in normal cells: in one BS LCL, the 
lower band was absent; in another, the upper band is ab- 
sent; and in two others, the intensity of the lower of the 
two bands was increased and the upper decreased. The 
RNA loading was equal in all the lanes as evidenced by 
hybridization with a probe for the glyceraldehyde-3- 
phosphate dehydrogenase (GBPD) gene. These observa- 
tions suggest that RNAs identified by the Hl cDNA might 
be destabilized in BS LCLs as result of mutations in the 
candidate gene (see Surdej et al., 1994). The derivation 
of the two RNA bands from the gene is unknown, and the 
cause of these abnormalities is under investigation. 
Figure 4. Amino Acid Sequence Homologies 
in the Seven Conserved Helicase Domains 
among the Putative Peptide Encoded by the 
Hl-5’ Sequence and the Three Other Known 
Members of the RecQ Subfamily of Helicases 
The numbers on the left indicate amino acid 
positions in each peptide, and gene product 
names are on the right. Sequence alignments 
were performed by the Megalign computer pro- 
gram (DNAStar); dashes indicate gaps in- 
serted by the program to maintain alignment. 
Amino acid residues that are identical at a posi- 
tion between sequences are stippled. Two dif- 
ferent stipplings are used when at a position 
two pairs of identical amino acids were ob- 
served. Overlined sequences mark the seven 
helicase domains (Gorbalenya et al., 1969). 
The DExH box is in helicase domain II. Aster- 
isks denote positions at which putative mis- 
sense mutations were identified. The candi- 
date gene product is referred to here as BLM 
because mutations have been discovered in 
the gene in persons with BS (see text). 
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Figure 5. Northern Blot Analysis of the Hl-5’ Sequences Expressed 
in Cultured Cells 
In (A), RNA preparations were analyzed from HG2162, a normal LCL; 
HG2635, a normal diploid fibroblast cell line; and HeLa cells. In (B), 
RNA preparations were analyzed from HG1943 and HG2162, which 
are normal LCLs, and from HG2703, HG1584, HGll987, HG1972, 
HG2231, HG1626, and HG2820, which are BS LCLs. Total RNA (30 
pg) from each cell line was loaded in each lane. Labt?led probes (the 
HI cDNA shown in the upper panels and a cDNA for G3PD shown in 
the lower panels) were hybridized to membranes of the blotted gels 
and, after washing, the membranes were exposed for l-3 days (Hl 
DNA) or for 15 min (GSPG cDNA). On a 7 day exposure, faint bands 
resembling the hybridization pattern in normal cells; were detected 
at the 4.5 kb position in HG2703, HG1584, and HG2820. The LCLs 
developed from persons with BS are shown in Table 1, except HG2703 
(NR2ICrSpej) and HG2820 (142[MaMatu]). 
Mutations in the Candidate Gene 
in Persons with BS 
To determine whether the candidate gene is BLM, we pre- 
pared RNAs from LCLs from 13 unrelated persons with 
BS and from cell lines from four unaffected comtrols. These 
RNAs were used to generate cDNAs for mutational analy- 
sis of the expressed sequences of the candidate gene. 
Sequences in these 13 BS and four control non-BS cDNAs 
were amplified in approximately 200 bp segments using 
PCR primers designed from the open reading frame in 
the Hl-5’ sequence (see Experimental Procedures). The 
amplified segments were analyzed by single strand con- 
formation polymorphism (SSCP) analysis using two condi- 
tions for electrophoresis. Novel SSCP conformers (Figure 
6) were identified, and the genetic changes underlying 
them were sequenced (Table 1). 
We identified seven unique mutations in ten persons 
with BS (the boxed and diamond-marked nucleotides in 
Figure 2), as well as four polymorphic base pairs that will 
not be described here. Of the mutations, four introduced 
premature nonsense codons into the coding sequence 
e 
Figure 6. Novel SSCP Conformers Detected in cDNA Samples Isolated 
from BS LCLs after PCR Amplification of the Candidate Gene 
Each panel includes five lanes of cDNAs from five unrelated persons 
with BS amplified with oligonucleotides designed from a unique region 
of the Candidate gene. The novel conformers in which mutati’ons were 
detected areshown in thecenterlanesof each panel: BS LCL HG1514 
from 15(MaRo) in (a), BS LCL HG1624 from llS(DaDem) ill (b), BS 
LCL HG1926 from 97(AsOk) in (c), BS LCL HG2231 from 139(ViKre) 
in (d), and BS LCL HG1626 from 93(YoYa) in (e). Not shown are the 
novel conformers detected in 92(VaBi) and 1 lP(NaSch). 
and three introduced amino acid substitutions(see lbelow); 
one of the four chain-terminating mutations arose by a 3 
bp deletion, one by a nucleotide substitution, one by a 1 
bp insertion that caused a frameshift, and one by a 6 bp 
deletion accompanied by a 7 bp insertion that also caused 
a frameshift. This last mutation was detected in <ali four 
persons with Ashkenazi Jewish ancestry. The potential 
products encoded in these four mutant alleles are 185, 
271, 515, and 739 amino acids in length, respectively, 
and none contains a complete set of the seven helicase 
domains. Of these mutant alleles, three were detected in 
the homozygous state, indicating that the persons; inher- 
iting them in double dose probably have no active BLM 
gene product in their cells. These observations a.re evi- 
dence that the Hl-5’ sequences are mutated in persons 
with BS, thereby proving that the candidate gene is BLM. 
Finally, two putative missense mutations were identified 
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Table I, Mutations Identified in the Candidate Gene in Persons with BS 
Positior? Zygosity at Codon Predicted 
Identification” Ancestry Cell Line (bp) Alteration Gene Kind Change Peptide” 
97(AsOk) Japanese HG1926 631 3 bp deletion’ Homozygous Nonsense S-stop 185 
112(NaSch) American/European HG2510 888 A-T Heteroygous Nonsense K-stop 271 
93(YoYa) Japanese HG1826 1610 1 bp insertion Homozygous Frameshift” Q+R’ 515 
139(ViKre) American/European HG2231 2089 A-G Heteroygous Missense 1417 
1 B(MaRo) Ashkenazi Jewish HG1514 2281 6 bp detetion and Homozygous Frameshift 739 
7 bp insertion 
42(RaFr) Ashkenazi Jewish HG2522 2281 6 bp deletion and Homozygous FrameshiW 739 
7 bp insertion 
107(MyAsa) Ashkenazi Jewish HG2654 2281 6 bp deletion and Homozygous Frameshifts 739 
7 bp insertion 
Nr2(CrSpe) Ashkenazi Jewish HG2727 2281 6 bp deletion and Homozygous FrameshiftQ 739 
7 bp insertion 
92(VaBi) Italian HG1584 2596 T-C Homozygous Missense 1-v 1417 
11 B(DaDem) Italian HG1824 3238 G-2 Homozygous Missense C-S 1417 
a Bloom’s Syndrome Registry designations. Three unrelated persons with BS were examined in whom mutations have yet to be detected: 61(DoH0), 
in HG2122; SO(MaKa), in HG1987; 140(DrKas), in HG1972. 
o The nucleotide positions are as identified in the Hl-5’ sequence (Figure 2). 
c Number of amino acids starting from the first in-frame ATG found in the Hl-5’ sequence (Figure 2). 
d The deletion of CAA at nucleotide positions 831-633 results in a stop codon at amino acid position 186 (Figure 2). 
e The insertion of an A base pair causes the insertion of a novel codon for K after amino acid 514 position (taken from the HI-5’ sequence; Figure 2). 
’ At amino acid position 672. 
9 The deletion of ATCTGA and insertion of TAGATTC causes the insertion of the novel codons for LDSR after amino acid position 736, and after 
these codons there is a stop codon. 
h At amino acid position 843. 
At amino acid position 1055. 
in two persons with BS that introduced amino acid substitu- 
tions at residues conserved in RecQ helicases (residues 
with asterisks in Figure 4), and one was identified that 
introduced an amino acid substitution of cysteine to serine 
in the carboxy-terminal region of the peptide. Because the 
three genetic alterations could be polymorphisms and the 
actual BS-associated mutations could have gone unde- 
tected, analyses of the BLM gene product in vitro will be 
required to demonstrate whether these substitutions 
cause the mutant phenotype. 
Discussion 
In the present study, BLM was isolated by a positional 
cloninq strategy. BLM first was localized by homozygosity 
mapping to a 2 CM interval flanking ES (German et al., 
1994), a gene already mapped to chromosome band 
15q26.1. A 2 Mb YAC and Pl contig encompassing ES 
was constructed, and closely spaced polymorphic DNA 
markers in the contig were identified (Straughen et al., 
submitted). BLM then was assigned by SCP mapping to 
a 250 kb interval in the contig, one bounded by the poly- 
morphic loci D75S7108 and 0358727(Figure 1). A cDNA 
clone (90528) was isolated by direct cDNA selection using 
a cosmid clone from the interval, and cDNA analysis identi- 
fiedthe4437bpH15’sequence(Figure2).Thissequence 
encodes a putative peptide homologous to the RecQ heli- 
cases (Figure 4). RNA transcripts 4.5 kb long were identi- 
fied by Northern blot analysis (Figure 5A), and electropho- 
retie abnormalities in RNAs were detected in cells from 
seven unrelated persons with BS, suggesting that these 
RNAs are derived from mutant BLM genes (Figure 58). 
Finally, reverse transcription PCR and SSCP analyses dis- 
closed seven unique mutations in ten persons with BS 
(Table 1; Figure 6), four that are chain terminating and 
three that are putative missense substitutions, two of the 
three affecting amino acid residues conserved in RecQ 
helicases and the third changing a cysteine to a serine. 
SCP Mapping, a Powerful Strategy 
In a recent tabulation of the 42 inherited disease- 
associated genes isolated by positional cloning (Collins, 
1995), 19 were transmitted as autosomal dominants and 
17 as X-linked recessives; however, only five were autoso- 
mal recessives. The reasons for the relative paucity of 
positionally cloned autosomal recessive disease-associated 
genes are at least twofold. First, the cloning of over half 
of the genes (26 of the 42 tabulated) was aided by chromo- 
some breakpoints within or near the disease-associated 
gene; however, only one of these was in an autosomal 
recessive. Second, and of greater importance, the number 
of families transmitting rare autosomal recessive disease- 
associated genes generally is small, and the number of 
persons in sibships who would be informative in recombi- 
national analysis also is small. Because a single investiga- 
tor usually cannot obtain the numbers of families required 
for linkage analysis, the localization and subsequent posi- 
tional cloning of rare autosomal recessive genes have 
lagged behind that of dominant and X-linked recessive 
genes. 
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Even when samples from numerous families have been 
collected and analyzed, usually the amount of positional 
information obtained is limited. In the case of BS, the 
Bloom’s Syndrome Registry (German iand Passarge, 
1989), a research resource that has provided the material 
for all our recent genetical studies, made possible an ex- 
tensive recombinational analysis of BLM by homozygosity 
mapping. This analysis permitted a minimum regional as- 
signment of BLM to approximately 1.3 Mb (unpublished 
data). This size of minimum interval is typical of recombi- 
national analysis. A search for and subsequent mutational 
analysis of genes from a 1.3 Mb region would have been 
laborious. 
The problem of tod little positional inforlmation in avail- 
able families can be mitigated in exceptional situations in 
which linkage disequilibrium between the disease-asso- 
ciated gene and tightly linked polymorphisms can be de- 
tected in a genetic isolate. In these cases, localization of 
a gene to a short interval in the genome by haplotype 
analysis can be more exact than is possible using standard 
linkage analysis of family data (e.g., Kerem et al., 1989; 
Sirugo et al., 1992; Lehesjoki et al., 1993; Hastbacka et 
al., 1994). Linkage disequilibrium in fact was a strategy 
available in BS (Ellis et al., 1994a), and it permitted a mini- 
mum regional assignment of BLM to the same 250 kb 
interval reported here (Ellis et al., submitted). This ap- 
proach could have allowed us to clone BLM. Instead, we 
first carried out SCP mapping. 
In the SCP mapping strategy, we took advantage of 
recombinant cell lines established from BS somatic cells 
in which crossing over within BLM had tatken place, re- 
sulting in the correction of the mutant phenotype in their 
progenies (Ellis et al., 1995). After a segregational event, 
all polymorphic loci distal to BLMwere reduced to homozy- 
gosity in half of the cases of intragenic recombination. This 
mapping method was preferred to linkage disequilibrium 
mapping because the crossovers that permitted localiza- 
tion of BLM had occurred within the gene itself and fewer 
genotypes were required for the analysis. IBY genotyping 
polymorphic loci that flank BLM in high SCE and low SCE 
samples from only five persons with BS ancl their parents, 
we delimited the position of BLM to the short interval 
bounded by the marker loci D15Sl108 and D15S127(Fig- 
ure 1). With BLM assigned to such a short interval, the 
cloning of BLM became straightforward. The first candi- 
date gene isolated from the interval proveld to be BLM. 
Loss-of-Function Mutations at BLM 
The candidate gene for BLM isolated from the interval 
identified by SCP mapping encodes a 14’17 amino acid 
peptide, homologousto RecQ helicases. Mutational analy: 
sis of the first 13 unrelated persons with BS examined 
permitted the identification of seven unique mutations in 
ten of them (Table 1). The fact that four of the seven muta- 
tions characterized so far result in premature termination 
of translation indicates that the cause of most BS is the 
loss of enzymatic activity of the BLMgene product. Identifi- 
cation of loss-of-function mutations in BLM (Table 1) is 
consistent with the autosomal recessive transmission of 
BS, and the homology of BLM and RecQ suggests that 
BLM has enzymatic activity. Thus, we predict ,that most 
BS mutations result in loss of function of BLM. 
This loss of enzymatic activity is not lethal in cells be- 
cause three of the chain-terminating mutations were de- 
tected in a homozygousstate. The nonlethalitycauld result 
from the existence of some residual enzymatic activity 
in the truncated peptides; however, this seems unlikely 
because one of the homozygous chain-terminatiing muta- 
tions results in chain termination after only 185 amino 
acids. Alternatively, the function of BLM may not be essen- 
tial for cell survival. Other factors in the cell may be able 
to substitute for BLM, albeit inefficiently. 
In the four persons with Jewish ancestry, a 8 bp deletion 
and 7 bp insertion at nucleotide 2281 were identiified, and 
each of the four persons was homozygous for the muta- 
tion. Homozygosity was predictable because linlkage dis- 
equilibrium had been detected in Ashkenazi Jews with 
BS between BLM, D75.927, and FES (Ellis et al., 1994a). 
Thus, a person who carried this 8 bp deletion and 7 bp 
insertion was a founder of the Ashkenazi Jewish popula- 
tion, and nearly all Ashkenazi Jews with BS inherit the 
mutation identical by descent from this common ancestor. 
Identification of the mutation now permits the screening 
of carriers in the Ashkenazim by a PCR test. 
BS is an autosomal recessive trait with high penetrance 
and expressivity. The observation of loss-of-function muta- 
tions in BLM helps to explain these genetic characteristics. 
The short stature, characteristic facies, facial sun sensitiv- 
ity, hyper- and hypopigmented patches on the skiin, immu- 
nodeficiency, male infertility, female subfertility, prema- 
ture menopause, and the predispositions to late onset 
diabetes and to neoplasia exist in virtually all groups of 
persons with the syndrome. The BS phenotype is similar 
in Ashkenazi Jews, the Dutch, the Flemish, Germmans, Ital- 
ians, Greeks, Turks, and Japanese; i.e., wherever it has 
been diagnosed. In addition, the elevated chromatid ex- 
change and the hypermutabilityare constant cellullar mani- 
festations. No more variability in the expressivity of the 
mutations has been detected in persons with BS’ who in- 
herit an identical mutation by descent from a common 
ancestor, as happens in Ashkenazi Jews with B!S and in 
nonAshkenazi Jewish persons with BS whose parents 
are cousins, than has been detected in persons who are 
compound heterozygotes(German et al., 1996). Nleverthe- 
less, with BLM cloned, it is possible to identify thle muta- 
tions in any person with BS, and more subtle genotype- 
phenotype correlations now can be carried out. 
BLM as a Putative DNA Helicase 
The BLM gene product contains amino acid moltifs that 
are homologous to motifs in the RecQ helicases (Figure 
‘4), a subfamily of DExH box-containing DNA and RNA 
helicases. red is an E. coli gene that is a member of the 
RecF recombination pathway (Nakayama et al., ‘l984), a 
pathway of genes in which mutations abolish the conjuga- 
tional recombination proficiency and ultraviolet (UV) resis- 
tance of a mutant strain lacking both RecBCD (part of 
exonuclease V) and SbcB (exonuclease I) activities (Horii 
and Clark, 1973). RecQ has DNA-dependent ATPase and 
DNA helicase activities and can translocate on single- 
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stranded DNA in a 3’5’ direction (Umezu et al., 1990). 
Besides BLM, only two other reck-like genes are known. 
First, SGS7 is a yeast gene in which mutations suppress 
the slow growth of cells carrying mutations in the TOP3 
topoisomerase gene (Gangloff et al., 1994). It also was 
isolated in a yeast two-hybrid screen through its interac- 
tions with both the yeast Top2p and Top3p topoisomer- 
ases (Gangloff et al., 1994; Watt et al., 1995). Second, 
RECQL is a human gene isolated from HeLa cells, the 
product of which possesses DNA-dependent ATPase, 
DNA helicase, and 3’5’ single-stranded DNA transloca- 
tion activities (Puranam and Blackshear, 1994; Seki et 
al., 1994). The homology of BLM to RecQ and RECQL 
suggests that BLM also has DNA-dependent ATPase and 
DNA helicase activities, and studies to investigate this 
have been initiated. 
In addition to helicase domains, BLM contains amino- 
terminal and carboxy-terminal regions that are composed 
predominantly of charged and polar amino acid residues. 
The presence of nonhelicase regions in BLM raises the 
possibility of additional enzymatic activities. The nonheli- 
case regions could operate to provide functional specificity 
to BLM, e.g., by promoting interactions with other proteins, 
or to provide substrates for phosphorylation that might 
regulate BLM activity in the cell cycle. 
A Function for BLM in DNA Replication 
Some genes in the DExH family have been implicated in 
DNA repair, and mutations in three of them, the XPB, XPD, 
and ERCCG genes, have been identified in the human dis- 
ease phenotypes xeroderma pigmentosum and Cock- 
ayne’s syndrome (Weber et al., 1990; Frejter et al., 1992; 
Troelstra et al., 1992; Sung et al., 1993; Ma et al., 1994). 
A universal function for the RecQ helicases, however, is 
not established. No abnormality in humans has been at- 
tributed to defects in RECQL. Even the cellular function 
of RecQ in bacteria is unclear, although it most likely par- 
ticipates in an aspect of postreplication recombinational 
repair (Luisi-DeLuca et al., 1989; Kusano et al., 1994; 
Tseng et al., 1994). The phenotype of yeast SGS7 mutants 
includes slow growth, poor sporulation, chromosome non- 
disjunction at mitosis, missegregation in meiosis (Watt et 
al., 1995) and an elevated recombination frequency 
(Gangloff et al., 1994). Sgslp is known to interact with 
topoisomerases II and Top3p and therefore may function 
in chromosome separation, a process in which intertwined 
DNA strands are resolved when replication forks con- 
verge. The predicted sizes of BLM (1417 residues) and 
Sgsl p (1447 residues) are similar, the two peptides have 
similar base compositions outside the helicase domains, 
and mutations in the genes encoding them result in geno- 
mic instability. In addition, an interaction between BLM 
and topoisomerase II in human cells was suggested by 
Heartlein et al. (1987), who observed that topoisomerase 
II activity is decreased in BrdU-treated BS cells. Although 
these interesting similarities are inconclusive, a possible 
functional homology between BLM and Sgslp warrants 
further investigation. 
In general, BLM has been implicated in the complex 
processes of DNA replication. Mutations in BLM have 
impressively pleiotropic cytogenetic and biochemical con- 
sequences. The chromosome breaks, gaps, and translo- 
cations and the high frequency of intra- and interchromo- 
somal strand exchanges all point to a disturbance of DNA 
replication. In BS cells, the rate of nascent DNA chain 
elongation is retarded (Hand and German, 1975; Giannelli 
et al., 1977), and the distribution of DNA replicational inter- 
mediates is abnormal (Lonn et al., 1990). Some, though 
not all, cultured BS cells exhibit increased sensitivity to 
DNA-damaging agents, e.g., UV radiation, mitomycin C, 
N-nitroso-N-ethylurea, and ethyl methanesulfonate (Krep- 
insky et al., 1979, 1980; lshizaki et al., 1981; Heddle et 
al., 1983; Kurihara et al., 1987). Disturbances in several 
enzymes that participate in DNA replication, DNA repair, 
or both have been identified in some, though, again, not 
all BS cell lines, including DNA ligase I (Chan et al., 1987; 
Willis and Lindahl, 1987), topoisomerase II in BrdU-treated 
BS cells (Heartlein et al., 1987) thymidylate synthetase 
(Shiraishi et al., 1989), uracil-DNA glycosylase (Seal et 
al., 1988), N-methylpurine DNA glycosylase (Dehazya and 
Sirover, 1986), OS-methylguanine methyltransferase (Kim 
et al., 1986), and superoxide dismutase (Nicotera et al., 
1989). These investigations show that certain enzymes 
concerned with DNA replication, repair, or both appear to 
be dysregulated in BS and that cultured BS cells make 
variously abnormal responses to DNA-damaging agents. 
The evidence that BS cells have a defect in DNA repair, 
however, is slight (Friedberg et al., 1979; German and 
Schonberg, 1980). BS cells in general are not hypersensi- 
tive to UV or X-ray irradiation by standard assays, and no 
defect in a specific DNA repair enzyme or pathway has 
been reported. Although the explanation for the pleiotropic 
effects of BS mutations still is unknown, the predicted func- 
tion of BLM as a DNA helicase suggests that the BS cell 
encounters greater difficulties than normal in the resolu- 
tion of specific DNA structures generated during DNA rep- 
lication. BLM presumably is one member of an assembly 
of gene products that acts in a pathway to resolve these 
structures. The excessive rates of chromatid exchange 
(homologous chromatid interchange configurations at 
metaphase and the SCE) might be microscopically visible 
manifestations of repair processes that are activated by 
the inability of the mutant cell to resolve the structures 
properly. Identification of the substrates on which BLM 
operates represents one of the important areas for future 
investigation. 
Conclusions 
With the cloning of the BS gene BLM and the inference 
that its gene product is a putative DNA helicase, insight 
has been gained into the molecular basis of the genomic 
instability that is the most impressive feature of BS cells. 
The absence of the BLM gene product most likely destabi- 
lizes other enzymes that participate in DNA replication 
and repair, perhaps through direct interactions or through 
more general responses to DNA damage. Elucidation of 
the enzymatic activities of BLM, the factors with which it 
interacts, and the substrates on which it operates now are 
required to understand the role of BLM in the maintenance 
of genomic stability. 
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Experimental Procedures 
Subjects and Samples 
The persons with BS in whom low SCE lymphocytes have arisen have 
been described previously (German et al., 1996). Epstein-Barr virus- 
transformed LCLs were developed from these and other persons with 
BS by standard culture methods using material obtained through the 
Bloom’s Syndrome Registry (German and Passarige, 1989). The re- 
combinant low SCE LCLs in which reduction to lhomozygosity had 
been detected and the cells used to determine the constitutional geno- 
types of the five persons from whom these recombinant low SCE LCLs 
were developed also have been described previ’ously (Ellis et al., 
1995). The polymorphic loci typed included some previously reported 
(Beckmann et al., 1993; Gyapay et al., 1994) and others that were 
identified during the physical mapping of the BLM region of chromo- 
some 15 (Straughen et al., submitted). The methods of preparation 
of DNA samples, oligonucleotide primers, and conditions for PCR am- 
plification of microsatellite polymorphisms on chromosome 15 have 
been described previously (German et al., 1994; Ellis et al., 1994a; 
Straughen et al., submitted). 
Direct cDNA Selection 
Direct cDNA selection was carried out as described by Parimoo et 
al. (1991). In brief, DNAs (15 ng) from commercial h cDNA libraries 
prepared from cultured foreskin fibroblasts (Clontech) and Jurkat cells 
(Stratagene) were amplified by PCR (94°C for 1 min, 55’C for 1 min, 
72OC for 2 min and 10 s for 32 cycles) using primer set A 
(GGTGGCGACGACTCCTGGAandACCAGACCAACTGGTAATG)for 
the fibroblast cDNA library and the universal forward and reverse Ml3 
sequencing primers for the Jurkat cDNA library under standard condi- 
tions with Taq polymerase (Boehringer Mannheiml). EcoRCdigested 
cosmid (c905) or Pl (P19.58) DNAs (100 ng) bound tie Hybond-N mem- 
brane in 10 x SSC were denatured in 0.5 M NaOH, 1.5 M NaCI; neutral- 
ized in 0.5 M Tris-HCI (pH 7.2), 1.5 M NaCI; and fixed by UV cross- 
linking. Hybridization of the PCR-amplified cDNAs to repetitive 
sequenceson thecosmidandpl cloneswas blocked byprehybridizing 
the membranes with Cot1 DNA (25 nglpl; GIBCO IBRL), poly(dl).po- 
ly(dC) (20 nglpl; Pharmacia), vector DNA (pWE15 or pADlOSacBll at 
25 ng/bl) in 5x SSPE, 5x Denhardt’s solution, and 0.5% SDS at 
65OC overnight. Hybridization of the PCR-amplified cDNAs (25 nglpl) 
was at 65OC for 2 days in the same solution without poly(dl).poly(dC). 
The membranes were washed, and without elution the bound cDNAs 
were amplified by PCR with primer set A, followed by nested PCR 
with primer set B (ATGGTAGCGACCGGCGCTCA and CCGTCAG- 
TATCGGCGGAATT’) for the fibroblast library and the T3 and T7 se- 
quencing primers for the Jurkat library. A sample of the PCR product 
after each amplification was analyzed by agarose gel electrophoresis, 
and another was cloned into Bluescript. Independent clones were 
picked at random, plasmid DNAs were prepared, and insert sizes were 
determined by restriction enzyme digestion and agarose gel electro- 
phoresis. Inserts from selected clones were purified and used as hy- 
bridization probes against all of the other clones as well as against 
selected genomic DNAs to determine the chromosomal origin of the 
sequences (see below). The enrichment procedure was repeated and 
the selected cDNA clones analyzed again. The fibmblast cDNA clone 
905-28 was obtained after two rounds of selection (250,000-fold en- 
riched) and was sequenced by the dideoxy chain termination tech- 
nique (Sanger et al., 1977; Tabor and Richardson, 1987). 
The genomic origin of clones isolated by direct selection was veri- 
fied by hybridization of inserts to Southern blots of DNAs from the 
following: clones in the contig; human cells; and two human x hamster 
somatic cell hybrids, one of which contains an intact chromosome 15 
as the only human chromosome present (GS89K-1; Warburton et al., 
1990) and one in which the only chromosome 15 material present had, 
through a translocation, lost all the sequences distal to band 156125 
(GM10664; obtained from the NIGMS Human Genetic Mutant Cell 
Repository at the Coriell Institute for Medical Research). 
cDNA Cloning, 5’ RACE, and cDNA Sequencing 
The selected cDNA 905-28 was hybridized to lo6 clones from a HeLa 
cDNA library (Stratagene) according to standard procedures (Sam- 
brook et al., 1989). We isolated 28 h clones and clonverted them to 
Bluescript plasmids by superinfection with ExAssist helper phage 
(Stratagene). DNA was prepared, and 15 independent size classes of 
clones were identified. The 5’ end of a clone from each class was 
sequenced with Bluescript SK sequencing primer. To extend the se- 
quence, we synthesized two oligonucleotides from the beNginning and 
the end of each of the 5’ sequences, and sequencing was performed 
on the largest cDNA clone obtained by hybridization (clone Hl). This 
procedure provided sequences from both DNA strands for most of the 
Hi cDNA. Ambiguous segments were determined by sequlencing with 
specific oligonucleotides. 
Because the reading frame was open at the 5’end of thle Hl clone, 
additional upstream sequences were obtained by a PCR method. PCR 
was carried out on DNA prepared from the HeLa cDNA library using 
an oligonucleotide (W 77, TTGTGGTGTTGGGTAGAGGTT) 8 bp from 
the 5’ end of Hl and the T3 sequencing primer. The PCR products 
were cloned into pT7Blue (Novagen), 18 clones were isolated, and 
the eight largest inserts were sequenced. The three largest of these 
clones (5’-5, 5’-15, and 5’-17) extended the sequences 289 bp 5’ of 
the Hl cDNA. We refer to the complete cDNA sequences present in 
the HeLa library as Hl-5’ (Figure 2). Database searches, then were 
carried out according to the method of Altschul et al. (11990) using 
segments of the predicted amino acid sequence encoded in the Hi-5’ 
sequence as queries against the collected amino acid sequence data- 
bases that are accessible through the National Library of Medicine. 
A full-length clone referred to as B3 was constructed by performing 
PCR of HeLa library DNA using an oligonucleotide (y780, GAG- 
GCNCGGCGGCCGTGGTTGC) from the 5’end of the Hl-Ei’sequence 
and an internal oligonucleotide (BC73, CCTCAGTCAAI\TCTATTT- 
GCTC) that permitted amplification of a739 bp product. Eagl and Smal 
sites (Figure 2) were used to clone the product into Notl-Smal-digested 
Hl DNA. 
The 461 bp Eagl-Smal fragment of 83 was isolated and used to 
probe 8 x lo6 ctones of a pREPCcloned unidirectional cDNA library 
from DEB-treated lymphoblastoid cells (Strathdee et al., 1992). We 
identified 12 cDNA clones, and the 5’ end of 11 were sequenced. Of 
these, eight are apparently full-length cDNAs (Figure 3). By restriction 
enzyme analysis, one of the 12 clones was shown to contain a deletion 
3’ of nucleotide 2897 and the insertion of about 250 bp there. 
5’ RACE was performed to characterize the 5’ sequences of the 
candidate gene using a Clontech Marathon cDNA amphfication kit 
according tothespecificationsofthemanufacturer. In brief, first-strand 
synthesis was carried out with MMLV reverse transcriptase using po- 
ly(T)-primed RNAs prepared from cultured fibroblast, lymplhoblastoid, 
and HeLa cells and poly(A)t RNA from placenta (provided in the kit). 
Then, second-strand synthesis was performed with RNase H, E. coli 
polymerase I, and E. coli DNA ligase. The DNA ends were made blunt 
with T7 DNA polymerase, and adapters with overhanging ends were 
ligated to the cDNA. Nested PCRs then were carried out using 5 
oligonucleotides from the adaptor (API and AP2) and internal 3’oligo- 
nucleotides from the Hl-5’ sequence (6C5, GCCATCACCGGAACA- 
GAAGGAA; BCI 7, TCTTCTGGAGAAGGTGGAACAA). Bandsderived 
from the Hld’sequences were identified in all four of the cDNA sam- 
ples. PCR products from the 5’RACE-amplified fibroblast cDNA were 
cloned into Bluescript, and the 5’ ends of 12 clones were sequenced 
(Figure 3). 
Northern Blot Analysis 
RNAs were prepared from cultured cells using TRlzol reagent (GIBCO 
BRL) according to the instructions of the manufacturer. Total RNAs 
(30 pg) were size separated by electrophoresis through 6.3% formalde- 
hyde, 1.2% agarose gels in 0.02 M MOPS, 0.05 M sodium acetate 
(pH 7.0), and 0.001 M EDTA. The RNAs were transferred to Hybond-N 
(Amersham) in 20 x SSPE and fixed to the membranes by UV cross- 
linking. Hybridizations were performed as described previously (Ellis 
et al., 1994b). 
SSCP Analysis 
After first-strand synthesis, PCR was carried out with 200 ng of cDNA, 
5.2 pmol of each oligonucleotide primer (Table 2), 3% DMSO, 0.2 mM 
dNTPs (Pharmacia), 1 x reaction buffer from Boehringer Mannheim, 
0.25 U of Taq polymerase (Boehringer Mannheim), and 1.0 &i of 
[a-3ZP]dCTP in a total volume of 10 ~1. Each reaction was overlaid with 
mineral oil and initially denatured for 5 min at 94“C followed by 35 
cycles of 94°C for 1 min, 60°C for 1 min, and 72°C for 1 min. The 
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Table 2. Pairs of Primer Sequences Used for SSCP Analysis of BLM 
Name 
Cl-B 
Cl-A 
Cl-l 
Cl-2 
Cl-3 
Cl-4 
Cl-5 
Cl-6 
Cl-7 
Cl-9 
Cl-10 
Cl-11 
Cl-12 
Cl-13 
Cl-14 
Cl-15 
Cl-16 
Cl-17 
Cl-18 
Cl-19 
Cl-20 
Cl-21 
Cl-22 
Cl-23 
Cl-24 
Cl-25 
Cl-26 
Cl-27 
Cl-28 
Cl-29 
Cl-30 
a 51-3’. 
Forward Sequence” Reverse Sequence” Product Length (bp) 
GGATCCTGGTTCCGTCCGC GAGGTTCACTGAAGGAAAAGTC 269 
CAACTAGAACGTCACTCAGCC GAAGTCCTTGACCCTTTGCTG 233 
GACTTTTCCTTCAGTGAACCTC GGGATTTCTTTACAGTTGGTGTG 186 
CCAGATTTCTTGCAGACTCCG CTCTTACAAAGTGACTTTGGGG 213 
CTTTAAGTACCATCAATGATTGGG CCTCAGTCAAATCTATTTGCTCG 227 
GAGTAAGCACTGCTCAGAAATC GCTTAACCATTCTGAGTCATCC 160 
CGAGCAAATAGATTTGACTGAGG CAATACATGGAACTTTCTCAGTTG 223 
GAAGATGCTCAGGAAAGTGAC CGTACTAAGGCATTTTGAAGAGG 215 
CAACTGAGAAAGTTCCATGTATTG CACAGTCTGTGCTGGTTTCTG 239 
CTATTCCTGATGATAAACTGAAAC CCTTCATAGAATTCCCTGTAGG 200 
GTGGAGATACAGGCCTGATTC GTGTTTCAGCCCAGTTGCTAC 244 
CAGGATTCTCTGCCACCAGG GCAGTATGTTTATTCTGATCTTTC 163 
CAGGAAATGTTCTCACAAGCAC CCTTGATGGGTTGATAGGCAG 203 
CAGCCAGCAAATCTTCCACAG CGCTCATGTTTCAGATTTCTGG 204 
GAATTATACTGACAAGTCAGCAC GATCTACGATAAGTGATCTCAAG 295 
CTCCTGGGGTCACTGTTGTC GAGTCTGTTACTTGCACAGATC 211 
CAATCATAAAACTTCTATATGTCAC GCCATCACCGGAACAGAAGG 207 
GTGGGGACATGATTTTCGTCAAG GATTATGTCTGTTAAAGCTCATG 175 
GACATCCTGACTCAGCTGAAG CGTGTCAGCCATGGTGTCAC 203 
GCACCACCCATATGATTCAGG CAGATAACCTGACAGCCATCC 179 
GATGAAGTGCAGCAGAAGTGG CAGTCTGGTCACATCATGATAG 221 
GCAGAGCTGGAAGAGATGGG GCTGTATTCTCCTGCATTCCG 168 
GTATAGCATGGTACATTACTGTG CCTTGTGATGAACTATGTTCTTG 228 
GACTGACGATGTGAAAAGTATTG CCAAAATCTTGTCAAGTATCAGC 235 
CCAGTCAGGTATATTTGGAAAAG GGAATTTTCTGTTTCCATAAAGTC 206 
CGATCGCTTATGTGATGCTCG CAAGCTTCTTGAGAGTGACGG 248 
GAACTTACAGAAGTCTGCAAATC GATGTCCATTCAGAGTATTTCTG 208 
GGTGTTACTGAAGACAAACTGG GGGTATTTCCTCGTCAAGCTC 168 
GGATAAGCCTGTCCAGCAGC CCTAGATATCTTTCTACATGTGG 214 
GCTTCCAGTGGTTCCAAGGC GTTATGAGAATGCATATGAAGGC 204 
CTCAAGCGACATCAGGAGCC CAAGAATAACAGCTTTATAGTCAC 178 
last cycle was extended at 72% for 5 min. PCR products were diluted 
in 25 nl of 0.1% SDS, 10 mM EDTA and 25 ul of 95% formamide, 20 
mM EDTA, 0.5% bromophenol blue, and 0.5% xylene cyanol. Two 
conditions for electrophoresis were carried out for each set of reac- 
tions. In one, electrophoresis of a 90 mM Tris borate, 2 mM EDTA 
(pH 7.5) (GIBCO BRL), 35% MDE (AT Biochem) 10% glycerol gel 
was performed at room temperature, cooled by fans; in the other, 
electrophoresis of a 90 mM Tris borate, 2 mM EDTA (pH 7.5) (GIBCO 
BRL), 25% MDE (AT Biochem) gel was performed at 4%. Electropho- 
resis was carried out for both conditions at 40 W constant power in 
0.6 x TBE running buffer. After electrophoresis, gels were transferred 
to 3MM paper and dried on a vacuum slab dryer. Autoradiography 
overnight with Kodak XAR5 film without intensifying screens was suffi- 
cient to detect bands. 
DNA Sequencing of SSCP Conformers 
Isolation of DNA from SSCP conformers was performed as described 
previously by Groden et al. (1991, 1993). Each sample was analyzed 
by agarose gel electrophoresis to confirm the correct size. The remain- 
derof each sample was purified using Centricon 100 columns (Amicon) 
and sequenced using the dsDNA Cycle Sequencing System (GIBCO 
BRL) with the forward primer originally designed for SSCP analysis. 
Sequencing reactions were analyzed by electrophoresis through 5% 
denaturing polyacrylamide gels. Gels were dried and exposed to Hyp- 
erfilm-MP (Amersham) without intensifying screens. 
Acknowledgments 
We are grateful to Manuel Buchwald, University of Toronto, for provid- 
ing the lymphoblastoid cDNA library in pREP4; Dorothy Warburton, 
Columbia University, for providing the GS69K-1 cell line; and Larry 
Gelbert, Bristol Myers Squibb, for help in searching the expressed 
sequence database. We thank Norma Neff and James Ray for critical 
reading of the manuscript and Mary Claire King for valuable discussion 
and encouragement. This work was supported by the Lucille P. Markey 
Charitable Trust (J. Groden), the Center for Environmental Genetics 
at the University of Cincinnati grant ES-06096 (J. Groden), and the 
National Foundation for Jewish Genetic Disease (J. German), the New 
York Blood Center, and National Institutes of Health grants HD-04134, 
CA-50697, and GM-47890. 
Received October 12, 1995; revised October 26, 1995. 
References 
Altschul, S.F., Gish, W., Miller, W., Myers, E.W., and Lipman, D.J. 
(1990). Basic local alignment search tool. J. Mol. Biol. 275, 403-410. 
Beckmann, J.S., Tomfohrde, J., Barnes, R., Williams, M., Broux, O., 
Richard, I., Weissenbach, J., and Bowcock, A.M. (1993). A linkage 
map of human chromosome 15 with an average resolution of 2 CM 
and containing 55 polymorphic microsatellites. Hum. Mol. Genet. 2, 
201 g-2030. 
Chan, J.Y.H., Becker, F.F., and German, J. (1987). Altered DNAligase 
I activity in Bloom’s syndrome cells. Nature 325, 357-359. 
Collins, F.S. (1995). Positional cloning moves from perditional to tradi- 
tional. Nature Genet. 9, 347-350. 
Dehazya, P., and Sirover, M.A. (1986). Regulation of hypoxanthine 
DNA glycosylase in normal human and Bloom’s syndrome fibroblasts. 
Cancer Res. 46, 3756-3761. 
Ellis, N.A., Roe, A.M., Kozloski, J., Proytcheva, M., Falk, C., and Ger- 
man, J. (1994a). Linkage disequilibrium between the FES, 0158727, 
and BLM loci in Ashkenazi Jews with Bloom syndrome. Am. J. Hum. 
Genet. 55,453-460. 
Ellis, N.A., Ye, T.-Z., Patton, S., German, J., Goodfellow, P.N., and 
Weller, P. (1994b). Cloning of PBDX, an MICP-related gene that spans 
the pseudoautosomal boundary on chromosome Xp. Nature Genet. 
6, 394-400. 
The Bloom’s Syndrome Gene 
665 
Ellis, N.A., Lennon, D.J., Proytcheva, M., Alhadeff, B., Henderson, 
E.E., and German, J. (1995). Somatic intragenic recombination within 
the mutated locus BLM can correct the high SCE phenotype of Bloom 
syndrome cells. Am. J. Hum. Genet. 57, 1019-1027. 
Frejter, W.L., McDaniel, L.D., Johns, D., Friedberg, E.C., and Schultz, 
R.A. (1992). Correction of xeroderma pigmentostm complementation 
group D mutant cell phenotypes by chromosome and gene transfer: 
involvement of the human ERCCP DNA repair gene. Proc. Natl. Acad. 
Sci. USA 89, 261-265. 
Friedberg, EC., Ehmann, U.K., and Williams, J.I. (1979). Human dis- 
eases associated with DNA repair. Adv. Rad. Biol 8, 85-174. 
Gangloff, S., McDonald, J.P., Bendixen, C., Arthur, L., and Rothstein, 
R. (1994). The yeast type I topoisomerase Top3 interacts with Sgsl, 
a DNA helicase homolog: a potential eukaryotic reverse gyrase. Mol. 
Cell. Biol. 74, 8391-8398. 
German, J. (1993). Bloom syndrome: a mendelian prototype ofsomatic 
mutational disease. Medicine 72, 393-406. 
German, J., and Passarge, E. (1989). Bloom’s syndrome. XII. Report 
from the Registry for 1987. Clin. Genet. 35, 57-69. 
German, J., and Schonberg, S. (1980). Bloom’s syndrome. IX. Review 
of cytological and biochemical aspects. In Genetic and Environmental 
Factors in Experimental and Human Cancer, H.V. Gelboin, B. MacMa- 
hon, T. Matsushima, T.Sugimura, S.Takayama, and H. Takebe, eds. 
(Tokyo: Japan Scientific Societies Press), pp. 1755186. 
German, J., Roe, A.M., Leppert, M., and Ellis, N.A. (1994). Bloom 
syndrome: an analysis of consanguineous families assigns the locus 
mutated to chromosome band 15q26.1. Proc. Acad. Natl. Sci. USA 
97, 6669-6673. 
German, J., Ellis, N.A., and Proytcheva, M. (1996). Bloom’ssyndrome. 
XIX. Cytogenetic and population evidence for genetic heterogeneity. 
Clin. Genet., in press. 
Giannelli, F., Benson, P.F., Pawsey, S.A., and Polani, P.E. (1977). 
Ultraviolet light sensitivity and delayed DNA-chain maturation in 
Bloom’s syndrome fibroblasts. Nature 265, 466-469. 
Gorbalenya, A.E., Koonin, E.V., Donchenko, A.P., and Blinov, V.M. 
(1989). Two related superfamilies of putative heliicases involved in 
replication, recombination, repair, and expression of DNA and RNA 
genomes. Nucl. Acids Res. 77, 4713-4730. 
Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Al- 
bertsen, H., Joslyn, G., Stevens, J., Spirio, L., Robertson, M., 
Sargeant, L., Krapcho, K., Wolff, E., Burt, O., Hughes, J.P., War- 
rington, J., McPherson, J., Wasmuth, J., LePaslier, D., Abderrahim, 
H., Cohen, D., Leppert, M., and White, R. (1991). Identification and 
characterization of the familial adenomatous coli gene. Cell 66, 589- 
600. 
Groden, J., Gelbert, L., Thliveris, A., Nelson, L., Robertson, M., Joslyn, 
G., Samowitz, W., Spirio, L., Carlson, M., Burt, R., Leppert, M., and 
White, R. (1993). Mutational analysis of patients with adenomatous 
polyposis: identical inactivation mutations in unrelated inividuals. Am. 
J. Hum. Genet. 52, 263-272. 
Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, 
P., Marc, S., Bernardi, G., Lathrop, M., and Weissenbach, J. (1994). 
The 1993-1994 Genethon human genetic linkage map. Nature Genet. 
7, 246-339. 
Hand, R., and German, J. (1975). A retarded rate of DNA chain growth 
in Bloom’s syndrome. Proc. Natl. Acad. Sci. USA 72, 758-762. 
Hastbacka, J., de la Chapelle, A., Mahtani, M.M., Clines, G., Reeve- 
Daly, M.P., Daly, M., Hamilton, B.A., Kusumi, K., Trivedi, B., Weaver, 
A., Coloma, A., Lovett, M., Buckler, A., Kaitila, I., and Lander, E.S. 
(1994). The diastrophic dysplasia gene encodes a novel sulfate trans- 
porter: positional cloning by fine-structure linkage disequilibrium map- 
ping. Cell 78, 1073-1087. 
Heartlein, M.W., Tsuji, H., and Latt, S.A. (1987). 5-Bromodeoxyuridine- 
dependent increase in sister chromatid exchange forlnation in Bloom’s 
syndrome is associated with reduction in topoisomerase II activity. 
Exp. Cell Res. 769, 245-254. 
Heddle, J.A., Krepinsky, A.B., and Marshall, R.R. (19183). Cellular sen- 
sitivity to mutagens and carcinogens in the chromosome-breakage 
and other cancer-prone syndromes. In Chromosorne Mutation and 
Neoplasia, J. German, ed. (New York: Alan R. Liss), pp. 203-234. 
Horii, Z., and Clark, A.J. (1973). Genetic analysis of the RecF pathway 
of genetic recombination in Escberichia co/iK-12. J. Mol. Biol. 80,327- 
344. 
Ishizaki, K., Yagi, T., Inoue, M., Nikaido, O., and Takebe, H. (1981). 
DNA repair in Bloom’s syndrome fibroblasts after UV irradiation or 
treatment with mitomycin C. Mutat. Res. 80, 213-219. 
Kerem, B.-S., Rommens, J.M., Buchanan, J.A., Markiewicz, D., Cox, 
T.K., Charkravarti, A., Buchwald, M., and Tsui, L.-C. (1989)l. Identifica- 
tion of the cystic fibrosis gene: genetic analysis. Science 245, 1073- 
1080. 
Kim, S., Vollberg, T.M., Ro, J.Y., Kim, M., and Sirover, M.A. (1986). 
06-methylguanine methyltransferase increases before S phase in nor- 
mal human cells but does not increase in hypermutable Bloom’s syn- 
drome cells. Mutat. Res. 773, 141-145. 
Kozak, M. (1989). The scanning model for translation: an update. J. 
Cell Biol. 108, 229-241. 
Krepinsky, A.B., Heddle, J.A., and German, J. (1979). Sensitivity of 
Bloom’s syndrome lymphocytes to ethyl methanesulfoniate. Hum. 
Genet. 50, 151-156. 
Krepinsky, A.B., Rainbow, A.J., and Heddle, J.A. (1980). Studies on 
the ultraviolet light sensitivity of Bloom’s syndrome fibroblasts. Mutat. 
Res. 69, 357-368. 
Kurihara, T., Inoue, M., and Tatsumi, K. (1987). Hypersensitivity of 
Bloom’s syndrome fibroblasts to N-ethyl-N-nitrosourea. Mutat. Res. 
784, 147-151. 
Kusano, K., Sunohara, Y., Takahashi, N., Yoshikura, H., and Kobay- 
ashi, I. (1994). DNA double-strand break repair: genetic determinants 
of flanking crossing-over. Proc. Natl. Acad. Sci. USA 97, 1173-1177. 
Lehesjoki, A.E., Koskiniemi, M., Novro, R., Tirrito, S., Sistonen, P., 
Lander, E., and de la Chapelle, A. (1993). Localization of the FM7 
gene for progressive myoclonus epilepsy on chromosome 21: linkage 
disequilibrium allows high resolution mapping. Hum. Mol. Genet. 2, 
1229-l 234. 
Lonn, U., Lonn, S., Nylen, U., Winblad, G., and German, J. (1990). 
An abnormal profile of DNA replication intermediates in Bloom’s syn- 
drome. Cancer Res. 50, 3141-3145. 
Luisi-DeLuca, C., Lovett, ST., and Kolodner, R.D. (1989). Geneticand 
physical analysis of plasmid recombination in reck recC sbc6 and 
recB fecC &CA Escherichia co/i Ki 2 mutants. Genetics 722,269-278. 
Ma, L., Westbroek,A., Jochemsen, A.G., Weeda, G., Bosch, A., Boots- 
ma, D., Hoeijmakers, J.H.J., and van der Ed, A.J. (1994). Mutational 
analysis of ERCCS, which is involved in DNA repair and transcription 
initiation: identification of domains essential for the DNA repair func- 
tion. Mol. Cell. Biol. 74, 4126-4134. 
Mathew, S., Murty,V.V.V.S., German, J., andchaganti, R.S.K. (1993). 
Confirmation of 15q26.1 as the site of the FfS protooncogene by fluo- 
rescence in situ hybridization. Cytogenet. Cell Genet. 63, 33-34. 
McDaniel, L.D., and Schultz, R.A. (1992). Elevated sister chromatid 
exchange phenotype of Bloom syndrome cells is complemented by 
human chromosome 15. Proc. Natl. Acad. Sci. USA 89, 7968-7972. 
Nakayama, H., Nakayama, K., Nakayama, R., Irino, N., Nlakayama, 
Y., and Hanawalt, P.C. (1984). Isolation and genetic characterization 
ofathyminelessdeath-resistant mutantofEscherichiacoliKll2: identifi- 
cation of a new mutation (recQ7) that blocks the RecF pathway. Mol. 
Gen. Genet. 795, 474-480. 
Nicotera, T.M., Notaro, J., Notaro, S., Schumer, J., and !;andberg, 
A.A. (1989). Elevated superoxide dismutase in Bloom’s syndrome: a 
genetic condition of oxidative stress. Cancer Res. 49, 5239-5243. 
Parimoo,S., Patanjali,S.R., Shukla, H.,Chaplin, D.D.,andWeissman, 
S.M. (1991). cDNA selection: efficient PCR approach for the selection 
of cDNAs encoded in large chromosomal fragments. Proc. Natl. Acad. 
Sci. USA 88, 9623-9627. 
Puranam, K.L., and Blackshear, P.J. (1994). Cloning and characteriza- 
tion of RECQL, a potential human homologue of the Escherichia co/i 
DNA helicase RecQ. J. Biol. Chem. 47, 29838-29845. 
Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Clon- 
ing: A Laboratory Manual, Second Edition (Cold Spring Harbor, New 
York: Cold Spring Harbor Laboratory Press). 
Sanger, F., Nicklen, S., and Coulson, A.R. (1977). DNA sequencing 
Cell 
666 
with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74,5463- 
5467. 
Seal, G., Brech, K., Karp, S.J., Cool, B.L., and Sirover, M.A. (1988). 
Immunological lesions in human uracil DNA glycosylase: association 
with Bloom’s syndrome. Proc. Natl. Acad. Sci. USA 85, 2339-2343. 
Seki, M., Miyazawa, H., Tada, S., Yanagisawa, J., Yamaoka, T., Hos- 
hino, S., Ozawa, K., Eki, T., Nogami, M., Okumura, K., Taguchi, H., 
Hanaoka, F., and Enomoto, T. (1994). Molecular cloning of cDNA en- 
coding human DNA helicase Ql which has homology to Escherichia 
co/i RecQ helicase and localization of the gene at chomosome 12~12. 
Nucl. Acids Res. 22, 4566-4573. 
Shiraishi, Y., Taguchi, T., Ozawa, M., and Bamezai, Fi. (1989). Differ- 
ent mutations responsible for the elevated sister-chromatid exchange 
frequencies in Bloom syndromeand X-irradiated B-lymphoblastoid cell 
lines originating from acute leukemia. Mutat. Res. 271, 273-278. 
Sirugo, G., Keats, B., Fujita, R., Duclos, F., Purohit, K., Koenig, M., 
and Mandel, J.L. (1992). Friedreich ataxiain LouisianaAcadians: dem- 
onstration of a founder effect by analysis of microsatellite-generated 
extended haplotypes. Am. J. Hum. Genet. 50, 559-566. 
Strathdee, CA., Gavish, H., Shannon, W.R., and Buchwald, M. (1992). 
Cloning of cDNAs for Fanconi’s anemia by functional complementa- 
tion. Nature 356, 763-767. 
Sung, P., Bailly, V., Weber, C., Thompson, L.H., Prakash, L., and 
Prakash, S. (1993). Human xeroderma pigmentosum group D gene 
encodes a DNA helicase. Nature 365, 852-855. 
Surdej, P., Riedl, A., and Jacobs-Lorena, M. (1994). Regulation of 
mRNA stability in development. Annu. Rev. Genet. 28, 263-282. 
Tabor, S., and Richardson, CC. (1987). DNA sequence analysis with 
a modified T7 DNA polymerase. Proc. Natl. Acad. Sci USA 84, 4767- 
4771. 
Troelstra, C., van Gool, A., de Wit, J., Vermeulen, W., Bootsma, D., 
and Hoeijmakers, J.H.J. (1992). ERCCG, a member of a subfamily of 
putative helicases, is involved in Cockayne’s syndrome and preferen- 
tial repair of active genes. Cell 77, 939-953. 
Tseng, Y.-C., Hung, J.-L., and Wang, T.-C. (1994). Involvement of 
RecF pathway recombination genes in postreplication repair in UV- 
irradiated Eschefichia co/i cells. Mutat. Res. 375, 1-9. 
Umezu, K., Nakayama, K., and Nakayama, H. (1990). Escherichia co/i 
RecQ protein is a DNA helicase. Proc. Natl. Acad. Sci. USA 87,5363- 
5367. 
Warburton, D., Gersen, S., Yu, M.-T., Jackson, C., Handelin, B., and 
Housman, D. (1990). Monochromosomal rodent-human hybrids from 
microcell fusion of human lymphoblastoid cells containing an inserted 
dominant selectable marker. Genomics 6, 358-366. 
Watt, P.M., Louis, E.J., Borts, R.H., and Hickson, I.D. (1995). Sgsl: 
a eukaryotic homolog of E. coli RecQ that interacts with topoisomerase 
II in viva and is required for faithful chromosome segregation. Cell 81, 
253-260. 
Weber, C.A., Salazar, E.P., Stewart, S.A., andThompson, L.H.(1990). 
ERCCS: cDNA cloning and molecular characterization of a human 
nucleotide excision repair gene with high homology to yeast RAD3. 
EMBO J. 9, 1437-1447. 
Willis, A.E., and Lindahl, T. (1987). DNA ligase I deficiency in Bloom’s 
syndrome. Nature 325, 355-357. 
GenBank Accession Number 
The accession number for the sequence reported in this paper is 
U39817. 
